Fresenius Kabi Oncology reports net loss of Rs 7.76 crore in the March 2013 quarter
Capital MarketNet loss of Fresenius Kabi Oncology reported to Rs 7.76 crore in the quarter ended March 2013 as against net profit of Rs 1.68 crore during the previous quarter ended March 2012. Sales declined 32.64% to Rs 70.54 crore in the quarter ended March 2013 as against Rs 104.72 crore during the previous quarter ended March 2012.
For the Audited full year,net profit rose 58.17% to Rs 80.59 crore in the year ended March 2013 as against Rs 50.95 crore during the previous year ended March 2012. Sales rose 5.33% to Rs 496.25 crore in the year ended March 2013 as against Rs 471.12 crore during the previous year ended March 2012.
ParticularsQuarter EndedYear EndedMar. 2013Mar. 2012% Var.Mar. 2013Mar. 2012% Var.Sales70.54104.72
-33 496.25471.12
5 OPM %16.109.53
69 28.8214.00
106 PBDT14.243.56
300 147.4151.18
188 PBT7.71-2.49
LP 121.6227.21
347 NP-7.761.68
PL 80.5950.95
58 Powered by Capital Market - Live News
